Updates in IPF Chronic Cough From CHEST 2025 ++++

FEATURED ARTICLE Updates in IPF Chronic Cough From CHEST 2025 https://checkrare.com/updates-in-ipf-chronic-cough-from-chest-2025/ Philip Molyneaux, MD, PhD, a Professor of Interstitial Lung Disease (ILD) at Imperial College London and the Asthma+Lung UK Chair of Respiratory Research at Royal Brompton Hospital, where is also the Director of the UK National Institute for Health and Care Research (NIHR) Clinical Research Facility, discusses the results of the CORAL study. Updates in Refractory Chronic Cough From ERS 2025 https://checkrare.com/updates-in-refractory-chronic-cough-from-ers-2025/ Jacky Smith, MB, ChB, FRCP, PhD, Chair of Respiratory Medicine at the University of Manchester, discusses topline results from the phase 2a RIVER trial for patients with refractory chronic cough (RCC). Zopapogene Imadenovec in Treating Patients With Recurrent Respiratory Papillomatosis https://checkrare.com/zolapogene-imadenovac-in-treating-patients-with-recurrent-respiratory-papillomatosis/ Clint Allen, MD, Senior Investigator, and Scott Norberg, DO, Associate Research Physician at Center for Cancer Research at the National Cancer Institute, discuss results from a study testing the safety and efficacy of zolapogene imadenovac to treat patients with recurrent respiratory papillomatosis (RRP). Improving Health Equity in Hereditary Angioedema (HAE): A Panel Discussion https://checkrare.com/improving-health-equity-in-hereditary-angioedema-hae-a-panel-discussion/ Aleena Banerji, MD, Timothy Craig, DO, and Marc Riedl, MD, provide an overview of the discrepancies in care observed in certain patient populations, as well as a discussion on best practices to reduce those inequalities moving forward.